Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD).
Priya UpadhyayChing-Wen WuAlexa PhamAmir A ZekiChristopher M RoyerUrmila P KodavantiMinoru TakeuchiHasan BayramKent E PinkertonPublished in: Journal of toxicology and environmental health. Part B, Critical reviews (2023)
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, and its global health burden is increasing. COPD is characterized by emphysema, mucus hypersecretion, and persistent lung inflammation, and clinically by chronic airflow obstruction and symptoms of dyspnea, cough, and fatigue in patients. A cluster of pathologies including chronic bronchitis, emphysema, asthma, and cardiovascular disease in the form of hypertension and atherosclerosis variably coexist in COPD patients. Underlying causes for COPD include primarily tobacco use but may also be driven by exposure to air pollutants, biomass burning, and workplace related fumes and chemicals. While no single animal model might mimic all features of human COPD, a wide variety of published models have collectively helped to improve our understanding of disease processes involved in the genesis and persistence of COPD. In this review, the pathogenesis and associated risk factors of COPD are examined in different mammalian models of the disease. Each animal model included in this review is exclusively created by tobacco smoke (TS) exposure. As animal models continue to aid in defining the pathobiological mechanisms of and possible novel therapeutic interventions for COPD, the advantages and disadvantages of each animal model are discussed.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- cardiovascular disease
- cystic fibrosis
- end stage renal disease
- newly diagnosed
- global health
- type diabetes
- public health
- oxidative stress
- physical activity
- randomized controlled trial
- drug induced
- cardiovascular events
- coronary artery disease
- risk assessment
- sleep quality
- allergic rhinitis
- cardiovascular risk factors